Skip to content
DefDex

Federal award

SIEMENS HEALTHCARE DIAGNOSTICS INC.

FA286020C0048

Contract

Obligated and Ceiling

Obligated (net)
$163,094.13
Ceiling (potential value, not spending)
$326,188.24
Current value
$163,094.14
Gross positive obligations
$163,094.13

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
SIEMENS HEALTHCARE DIAGNOSTICS INC. · GC14SNHB3JN1
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
ALTAIR ENGINEERING INC. · XEAUKVYXD3W1
Awarding agency
Department of War · sub-agency 5700 · office FA2860
Funding agency
Department of War · sub-agency 97DH
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
FA286020C0048
Award type code
D
Actions
7 · Aug 17, 2020 to Dec 14, 2024
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History7

Award actions
DateFYModAction typeObligationCompany in company totals
Dec 14, 2024FY2025P00006B$0.00
—
Nov 5, 2024FY2025P00005M$0.00
—
Dec 15, 2023FY2024P00004G$37,637.11
—
Dec 14, 2022FY2023P00003G$37,637.10
—
Dec 10, 2021FY2022P00002G$37,637.11
—
Dec 14, 2020FY2021P00001G$37,637.11
—
Aug 17, 2020FY20200—$12,545.70
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.